Telerehabilitation as an Alternative to Face-to-Face Rehabilitation After Total Hip Arthroplasty

NCT ID: NCT06708884

Last Updated: 2024-11-27

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

NOT_YET_RECRUITING

Clinical Phase

NA

Total Enrollment

36 participants

Study Classification

INTERVENTIONAL

Study Start Date

2024-12-15

Study Completion Date

2025-04-15

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The goal of this clinical trial is to learn if telerehabilitation in patients who had undergone total hip arthroplasty. The main questions it aims to answer are:

* Does telerehabilitation improve the functional level of the participants?
* Does telerehabilitation improve the locomotor performance of the participants? Researchers will compare telerehabilitation to face to face rehabilitation (traditional rehabilitation programme) to see if telerehabilitation works in total hip arthroplasty recovery.

Participants will:

* Attend physiotherapy and rehabilitation sessions supervised by a physiotherapist 2 days a week for 8 weeks.
* Participate in assessments (before surgery and at 6 weeks and 12 weeks after surgery).

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Total Hip Arthroplasty (THA)

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

SINGLE

Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Group 1: TR Group

TR: telerehabilitation. During the follow-up period, a standard exercise programme will be applied to the TR group via videoconference-based telerehabilitation.

Group Type EXPERIMENTAL

Exercise

Intervention Type OTHER

exercise programme will be implemented via telerehabilitation

Group 1: F2F Group

F2F: face to face. During the follow-up period, a standard exercise programme will be applied to the F2F group via face to face rehabilitation.

Group Type EXPERIMENTAL

Exercise

Intervention Type OTHER

exercise programme will be implemented via face-to-face

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Exercise

exercise programme will be implemented via telerehabilitation

Intervention Type OTHER

Exercise

exercise programme will be implemented via face-to-face

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Having hip arthroplasty surgery
* To be able to understand verbal and written information
* No cognitive impairment
* To be able to speak and understand Turkish

Exclusion Criteria

* Having a neurological disease
* Having a psychiatric disorder
* Visual or hearing loss that cannot be corrected with any assistive device
Minimum Eligible Age

50 Years

Maximum Eligible Age

80 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Pamukkale University

OTHER

Sponsor Role collaborator

Burdur Mehmet Akif Ersoy University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Akın Süzer

Principal Investigator

Responsibility Role PRINCIPAL_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Burdur Mehmet Akif Ersoy University

Burdur, , Turkey (Türkiye)

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Turkey (Türkiye)

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Akın Süzer, PT, PhD

Role: CONTACT

05554843024

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

ErsoyU.22112024

Identifier Type: -

Identifier Source: org_study_id